The Selective Glycine Uptake Inhibitor Org 25935 as an Adjunctive Treatment to Atypical Antipsychotics in Predominant Persistent Negative Symptoms of Schizophrenia: Results From the GIANT Trial

Joep Schoemaker, Wim Jansen, Jacques Schipper, Armin Szegedi

Research output: Contribution to journalArticleScientificpeer-review

29 Citations (Scopus)

Fingerprint Dive into the research topics of 'The Selective Glycine Uptake Inhibitor Org 25935 as an Adjunctive Treatment to Atypical Antipsychotics in Predominant Persistent Negative Symptoms of Schizophrenia: Results From the GIANT Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences